Stetson PL - Search Results

1

Regional pharmacokinetics of 5-fluorouracil in dogs: role of the liver, gastrointestinal tract, and lungs.

Kuan HY, Smith DE, Ensminger WD, Knol JA, DeRemer SJ, Yang Z, Stetson PL. Kuan HY, et al. Among authors: stetson pl. Cancer Res. 1998 Apr 15;58(8):1688-94. Cancer Res. 1998. PMID: 9563484

2

Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.

Mancini WR, Stetson PL, Lawrence TS, Wagner JG, Greenberg HS, Ensminger WD. Mancini WR, et al. Among authors: stetson pl. Cancer Res. 1991 Feb 1;51(3):870-4. Cancer Res. 1991. PMID: 1824826

3

Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.

Lawrence TS, Davis MA, McKeever PE, Maybaum J, Stetson PL, Normolle DP, Ensminger WD. Lawrence TS, et al. Among authors: stetson pl. Cancer Res. 1991 Aug 1;51(15):3900-5. Cancer Res. 1991. PMID: 1830239

4

Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.

Stetson PL, Maybaum J, Wagner JG, Averill DR, Wollner IS, Knol JA, Johnson NJ, Yang ZM, Preiskorn D, Smith P, et al. Stetson PL, et al. Cancer Res. 1988 Dec 1;48(23):6900-5. Cancer Res. 1988. PMID: 3180098

5

Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.

Knol JA, Walker SC, Robertson JM, Yang Z, DeRemer S, Stetson PL, Ensminger WD, Lawrence TS. Knol JA, et al. Among authors: stetson pl. Cancer Res. 1995 Sep 1;55(17):3687-91. Cancer Res. 1995. PMID: 7641176

6

Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs.

Smith DE, Brenner DE, Knutsen CA, Deremer SJ, Terrio PA, Johnson NJ, Stetson PL, Ensminger WD. Smith DE, et al. Among authors: stetson pl. Drug Metab Dispos. 1993 Mar-Apr;21(2):277-83. Drug Metab Dispos. 1993. PMID: 8097697

7

Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridine.

Ensminger WD, Walker SC, Stetson PL, Wagner JG, Knol JA, Lawrence TS, Andrews JC. Ensminger WD, et al. Among authors: stetson pl. Cancer Res. 1994 Apr 15;54(8):2121-4. Cancer Res. 1994. PMID: 8174116

8

Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo.

Lawrence TS, Davis MA, Stetson PL, Maybaum J, Ensminger WD. Lawrence TS, et al. Among authors: stetson pl. Cancer Res. 1994 Jun 1;54(11):2964-8. Cancer Res. 1994. PMID: 8187082

9

Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.

Kuan HY, Smith DE, Ensmiger WD, Knol JA, DeRemer SJ, Yang Z, Stetson PL. Kuan HY, et al. Among authors: stetson pl. Cancer Res. 1996 Oct 15;56(20):4724-7. Cancer Res. 1996. PMID: 8840990

10

The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.

Lawrence TS, Davis MA, Maybaum J, Mukhopadhyay SK, Stetson PL, Normolle DP, McKeever PE, Ensminger WD. Lawrence TS, et al. Among authors: stetson pl. Cancer Res. 1992 Jul 1;52(13):3698-704. Cancer Res. 1992. PMID: 1617642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters